Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN103613602B reveals novel gambogic acid derivatives with enhanced solubility. Discover supply chain advantages and scalable synthesis for pharmaceutical intermediates.
Patent CN100361993C details a novel pyrrole-based route yielding high-purity brominated aldisin derivatives with reduced costs and improved supply chain reliability for global pharmaceutical manufacturing.
Patent CN101575298B details a cost-effective synthesis of chiral 2-amino-1-phenylethylalcohol from styrene glycol, offering high optical purity for beta-agonist manufacturing.
New one-step synthesis method for Oxiracetam intermediate. High yield, low waste, scalable production for pharmaceutical supply chains.
High-purity Topiroxostat manufacturing method removes amide impurities effectively ensuring supply chain stability and cost efficiency for pharmaceutical partners globally.
Patent CN102775389B reveals optimized synthesis for kinase inhibitors offering supply chain stability and cost efficiency for global pharmaceutical manufacturers.
Patent CN104152527A details DKR method for R-2-naphthylethylamine. High purity, cost-effective Raney Nickel catalyst. Reliable supply chain for pharmaceutical intermediates.
Novel route for Selamectin production using IBX oxidation improves purity and reduces wastewater treatment costs for veterinary drug manufacturers.
Novel camptothecin derivative patent CN104817574A offers high yield synthesis and improved anti-liver cancer activity for reliable pharmaceutical intermediates supplier partnerships.
Novel benzothiadiazole-based photosensitizer with high singlet oxygen yield and AIE effect for advanced cancer treatment applications and supply chain stability.
Discover the patented CN102134252B process for synthesizing >99% pure cefuroxime acid. Learn how ternary solvent extraction reduces lactone impurities and ensures supply chain stability.
Patent CN100537563C reveals a streamlined acid-catalyzed condensation for N-phenyl-2-pyrimidinamine derivatives, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel nitration route avoids chlorosulfonic acid hazards ensuring safer scalable production and cost reduction for pharmaceutical intermediates supply chains.
Patent CN111363736A reveals a novel enzymatic route for dexketoprofen using Klebsiella amidase, offering superior ee values and greener manufacturing for pharmaceutical intermediates.
Novel patent CN116496239A offers a green synthesis route for Venetoclax intermediates, ensuring high purity and supply chain reliability for global pharmaceutical procurement.
Patent CN102719378A reveals high-purity (-)-gamma-lactam production via Delftia sp., offering cost-effective API manufacturing solutions.
Novel C-H activation synthesis of high-B-ring berberine derivatives offers potent IDO1/TDO inhibition for oncology drug development.
Novel patent CN116410098B enables catalyst-free oxidation using sodium percarbonate for high-purity alpha-amino ketones ensuring supply chain reliability and cost efficiency.
Novel synthetic route for Entecavir using Corey lactone diol, offering cost reduction and scalability for pharmaceutical manufacturing supply chains.
Patent CN101870704A reveals a room-temperature purification method for cefotetan acid, drastically reducing isomer content and enhancing manufacturing efficiency for pharmaceutical intermediates.